Oversonic Robotics Srl believes that its humanoid robot Robee could transform health care in Europe as it helps address the ...

The Physicians Committee for Responsible Medicine welcomes the historic decision by the Dutch Senate to phase out public funding for primate experiments at the Biomedical Primate Research Centre (BPRC ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

When two of the most powerful people in the world enthusiastically discuss how science is on the verge of finding the secret ...

In a medical emergency, every second counts—but around the world, many people still hesitate or make the wrong decision when ...

Northern Ireland trials of a potentially life-saving cancer test have faced significant delays with EU rules were wrongly blamed for the hold-up. The Department of Health has now admitted there is ...

Dopamine is often called the brain's "motivation molecule," but for me, it represents something deeper, a window into how ...

Where are travelers going this holiday season, what insurance do they need and what are some strategies for buying insurance?

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

From lab bench to clinic, discover how a centuries-old superfruit translates into measurable gains in glycemic control, lipid profiles, skin health, and resilience against oxidative stress.

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter.

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.